Financial Health Educational Program for Increasing Financial Literacy Among Underserved Communities in Western New York
NCT ID: NCT05997589
Last Updated: 2025-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2023-05-17
2025-02-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses
NCT04960787
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
NCT07281287
Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
NCT06630962
Faith-Based African American Cancer Survivorship Storytelling
NCT03082612
Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers
NCT03775616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Collaborate with community organizations and leaders to leverage community-based assets to disseminate education about financial literacy.
II. Reach medically underserved, high risk community members. III. Enhance financial literacy knowledge among medically underserved, high risk community members.
OUTLINE:
Participants attend financial health educational program over 60 minutes. Patients also receive educational materials on study.
After completion of study intervention, patients are followed up to 30 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Services Research (educational program)
Participants attend financial health educational program over 60 minutes. Patients also receive educational materials on study.
Behavioral Intervention
Receive educational materials
Educational Intervention
Attend financial health educational program
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Intervention
Receive educational materials
Educational Intervention
Attend financial health educational program
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roswell Park Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Bouchard
Role: PRINCIPAL_INVESTIGATOR
Roswell Park Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roswell Park Cancer Institute
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-02314
Identifier Type: REGISTRY
Identifier Source: secondary_id
I 3445122
Identifier Type: OTHER
Identifier Source: secondary_id
I 3445122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.